US Stock MarketDetailed Quotes

ANTH Anthera Pharmaceuticals Inc

Watchlist

0.000001
0.0000000.00%

15min DelayClose Jul 22 16:00 ET

26.18Market Cap0.00P/E (TTM)

Anthera Pharmaceuticals Inc Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2018

(FY)Dec 31, 2017

(Q4)Dec 31, 2017

(Q3)Sep 30, 2017

(Q2)Jun 30, 2017

(Q1)Mar 31, 2017

(FY)Dec 31, 2016

(Q4)Dec 31, 2016

(Q3)Sep 30, 2016

(Q2)Jun 30, 2016

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

34.53%-9.38M

24.57%-36.9M

48.81%-6.26M

57.72%-6.2M

10.72%-10.11M

-33.87%-14.33M

-58.28%-48.92M

-29.36%-12.23M

-68.47%-14.66M

-84.45%-11.33M

Net income from continuing operations

31.08%-7.72M

51.60%-26.87M

25.51%-9.67M

61.72%-6.31M

102.18%313K

4.43%-11.21M

-57.65%-55.52M

-76.93%-12.99M

-45.49%-16.48M

-61.15%-14.33M

Operating gains losses

-648.33%-3.29M

-452.92%-9.64M

----

--600K

---1.74M

----

Depreciation and amortization

257.78%161K

5.64%281K

40.00%35K

-56.84%41K

116.22%160K

-37.50%45K

-6.67%266K

-65.28%25K

30.14%95K

2.78%74K

Other non cash items

----

---1.65M

----

Change In working capital

62.25%-1.83M

-475.50%-5.04M

409.82%1.52M

48.22%750K

-264.32%-2.46M

-2,788.69%-4.85M

175.77%1.34M

84.87%-489K

-59.16%506K

-25.37%1.49M

-Change in receivables

----

--0

138.31%100K

-130.67%-100K

200.00%326K

--0

160.42%261K

-363.64%-261K

-Change in prepaid assets

233.59%342K

167.97%870K

184.27%777K

335.32%1.02M

-72.82%-674K

-26.11%-256K

-533.66%-1.28M

-336.97%-922K

-17.25%235K

-292.12%-390K

-Change in payables and accrued expense

62.91%-1.11M

-342.83%-5.91M

70.44%738K

-2,830.00%-273K

-258.09%-3.39M

-1,852.29%-2.99M

-31.96%2.44M

123.32%433K

-99.48%10K

16.20%2.15M

-Change in other current liabilities

29.40%-1.07M

----

---1.51M

----

-Change in other working capital

----

94.62%-138K

--0

Cash from discontinued investing activities

Operating cash flow

34.53%-9.38M

24.57%-36.9M

48.81%-6.26M

57.72%-6.2M

10.72%-10.11M

-33.87%-14.33M

-58.28%-48.92M

-29.36%-12.23M

-68.47%-14.66M

-84.45%-11.33M

Investing cash flow

Cash flow from continuing investing activities

358K

-857.50%-766K

186K

-290K

Net PPE purchase and sale

--358K

--0

----

-857.50%-766K

--186K

---290K

----

Cash from discontinued investing activities

Investing cash flow

--358K

--0

-857.50%-766K

--186K

---290K

----

Financing cash flow

Cash flow from continuing financing activities

5.48%14.91M

-22.58%18.25M

655.56%2.38M

-94.10%1.12M

-76.57%612K

767.36%14.14M

-68.69%23.58M

-50.93%315K

-34.43%19.02M

14,411.11%2.61M

Net common stock issuance

-12.18%12.38M

171.10%18.25M

114.40%2.38M

-94.10%1.12M

-75.11%650K

765.03%14.1M

-91.06%6.73M

-2,674.61%-16.53M

-34.84%19.02M

1,722.36%2.61M

Net preferred stock issuance

----

--16.84M

----

Proceeds from stock option exercised by employees

6,560.53%2.53M

----

--38K

----

Cash from discontinued financing activities

Financing cash flow

5.48%14.91M

-22.58%18.25M

655.56%2.38M

-94.10%1.12M

-76.57%612K

767.36%14.14M

-68.69%23.58M

-50.93%315K

-34.43%19.02M

14,411.11%2.61M

Net cash flow

Beginning cash position

-89.46%2.2M

-55.61%20.84M

-81.34%6.08M

-60.87%11.15M

-45.48%20.65M

-55.61%20.84M

1,679.12%46.95M

-41.59%32.57M

-19.62%28.5M

-9.05%37.88M

Current changes in cash

3,183.77%5.89M

28.58%-18.65M

66.91%-3.88M

-224.69%-5.08M

-1.32%-9.5M

97.90%-191K

-158.92%-26.11M

-33.09%-11.73M

-79.96%4.07M

-51.41%-9.38M

End cash Position

-60.85%8.09M

-89.46%2.2M

-81.34%6.08M

-60.87%11.15M

-45.48%20.65M

-55.61%20.84M

-41.59%32.57M

-19.62%28.5M

Free cash flow

34.53%-9.38M

25.73%-36.9M

48.02%-6.26M

58.54%-6.2M

15.65%-10.11M

-33.87%-14.33M

-60.34%-49.69M

-27.39%-12.04M

-71.80%-14.95M

-93.03%-11.99M

Currency Unit

USD

Audit Opinions

Unqualified Opinion with Explanatory Notes

	(Q1)Mar 31, 2018	(FY)Dec 31, 2017	(Q4)Dec 31, 2017	(Q3)Sep 30, 2017	(Q2)Jun 30, 2017	(Q1)Mar 31, 2017	(FY)Dec 31, 2016	(Q4)Dec 31, 2016	(Q3)Sep 30, 2016	(Q2)Jun 30, 2016
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	34.53%-9.38M	24.57%-36.9M	48.81%-6.26M	57.72%-6.2M	10.72%-10.11M	-33.87%-14.33M	-58.28%-48.92M	-29.36%-12.23M	-68.47%-14.66M	-84.45%-11.33M
Net income from continuing operations	31.08%-7.72M	51.60%-26.87M	25.51%-9.67M	61.72%-6.31M	102.18%313K	4.43%-11.21M	-57.65%-55.52M	-76.93%-12.99M	-45.49%-16.48M	-61.15%-14.33M
Operating gains losses	-648.33%-3.29M	-452.92%-9.64M	----	----	----	--600K	---1.74M	----	----	----
Depreciation and amortization	257.78%161K	5.64%281K	40.00%35K	-56.84%41K	116.22%160K	-37.50%45K	-6.67%266K	-65.28%25K	30.14%95K	2.78%74K
Other non cash items	----	----	----	---1.65M	----	----	----	----	----	----
Change In working capital	62.25%-1.83M	-475.50%-5.04M	409.82%1.52M	48.22%750K	-264.32%-2.46M	-2,788.69%-4.85M	175.77%1.34M	84.87%-489K	-59.16%506K	-25.37%1.49M
-Change in receivables	----	----	----	--0	138.31%100K	-130.67%-100K	200.00%326K	--0	160.42%261K	-363.64%-261K
-Change in prepaid assets	233.59%342K	167.97%870K	184.27%777K	335.32%1.02M	-72.82%-674K	-26.11%-256K	-533.66%-1.28M	-336.97%-922K	-17.25%235K	-292.12%-390K
-Change in payables and accrued expense	62.91%-1.11M	-342.83%-5.91M	70.44%738K	-2,830.00%-273K	-258.09%-3.39M	-1,852.29%-2.99M	-31.96%2.44M	123.32%433K	-99.48%10K	16.20%2.15M
-Change in other current liabilities	29.40%-1.07M	----	----	----	----	---1.51M	----	----	----	----
-Change in other working capital	----	----	----	----	----	----	94.62%-138K	--0	--0	--0
Cash from discontinued investing activities
Operating cash flow	34.53%-9.38M	24.57%-36.9M	48.81%-6.26M	57.72%-6.2M	10.72%-10.11M	-33.87%-14.33M	-58.28%-48.92M	-29.36%-12.23M	-68.47%-14.66M	-84.45%-11.33M
Investing cash flow
Cash flow from continuing investing activities	358K	0	0	0			-857.50%-766K	186K	-290K
Net PPE purchase and sale	--358K	--0	--0	--0	----	----	-857.50%-766K	--186K	---290K	----
Cash from discontinued investing activities
Investing cash flow	--358K	--0	--0	--0	--0	--0	-857.50%-766K	--186K	---290K	----
Financing cash flow
Cash flow from continuing financing activities	5.48%14.91M	-22.58%18.25M	655.56%2.38M	-94.10%1.12M	-76.57%612K	767.36%14.14M	-68.69%23.58M	-50.93%315K	-34.43%19.02M	14,411.11%2.61M
Net common stock issuance	-12.18%12.38M	171.10%18.25M	114.40%2.38M	-94.10%1.12M	-75.11%650K	765.03%14.1M	-91.06%6.73M	-2,674.61%-16.53M	-34.84%19.02M	1,722.36%2.61M
Net preferred stock issuance	----	----	----	----	----	----	--16.84M	----	----	----
Proceeds from stock option exercised by employees	6,560.53%2.53M	----	----	----	----	--38K	----	----	----	----
Cash from discontinued financing activities
Financing cash flow	5.48%14.91M	-22.58%18.25M	655.56%2.38M	-94.10%1.12M	-76.57%612K	767.36%14.14M	-68.69%23.58M	-50.93%315K	-34.43%19.02M	14,411.11%2.61M
Net cash flow
Beginning cash position	-89.46%2.2M	-55.61%20.84M	-81.34%6.08M	-60.87%11.15M	-45.48%20.65M	-55.61%20.84M	1,679.12%46.95M	-41.59%32.57M	-19.62%28.5M	-9.05%37.88M
Current changes in cash	3,183.77%5.89M	28.58%-18.65M	66.91%-3.88M	-224.69%-5.08M	-1.32%-9.5M	97.90%-191K	-158.92%-26.11M	-33.09%-11.73M	-79.96%4.07M	-51.41%-9.38M
End cash Position	-60.85%8.09M	-89.46%2.2M	-89.46%2.2M	-81.34%6.08M	-60.87%11.15M	-45.48%20.65M	-55.61%20.84M	-55.61%20.84M	-41.59%32.57M	-19.62%28.5M
Free cash flow	34.53%-9.38M	25.73%-36.9M	48.02%-6.26M	58.54%-6.2M	15.65%-10.11M	-33.87%-14.33M	-60.34%-49.69M	-27.39%-12.04M	-71.80%-14.95M	-93.03%-11.99M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Audit Opinions	--	Unqualified Opinion with Explanatory Notes	--	--	--	--	Unqualified Opinion with Explanatory Notes	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall